Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases

Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is uncommon with an estimated all time incidence around 1% worldwide. Moreover, a case of gefitinib ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Yon Ju, Chun, Eun Mi, Lee, Soon Nam, Shim, Sung Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2014
Materias:
Thoracic Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955799/
https://www.ncbi.nlm.nih.gov/pubmed/24642811
http://dx.doi.org/10.3348/kjr.2014.15.2.300
_version_ 1782307626288152576
author Ryu, Yon Ju
Chun, Eun Mi
Lee, Soon Nam
Shim, Sung Shin
author_facet Ryu, Yon Ju
Chun, Eun Mi
Lee, Soon Nam
Shim, Sung Shin
author_sort Ryu, Yon Ju
collection PubMed
description Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is uncommon with an estimated all time incidence around 1% worldwide. Moreover, a case of gefitinib associated with pulmonary cystic changes has not been reported yet. In this report we present a case of progressive multiple air cystic changes in both lungs in a patient with NSCLC and intrapulmonary metastases who underwent a gefitinib therapy.
format Online
Article
Text
id pubmed-3955799
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-39557992014-03-18 Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases Ryu, Yon Ju Chun, Eun Mi Lee, Soon Nam Shim, Sung Shin Korean J Radiol Thoracic Imaging Gefitinib is regarded as a relatively safe agent for the treatment of an advanced non-small cell lung cancer (NSCLC). Pulmonary toxicity such as interstitial lung disease associated with gefitinib is uncommon with an estimated all time incidence around 1% worldwide. Moreover, a case of gefitinib associated with pulmonary cystic changes has not been reported yet. In this report we present a case of progressive multiple air cystic changes in both lungs in a patient with NSCLC and intrapulmonary metastases who underwent a gefitinib therapy. The Korean Society of Radiology 2014 2014-03-07 /pmc/articles/PMC3955799/ /pubmed/24642811 http://dx.doi.org/10.3348/kjr.2014.15.2.300 Text en Copyright © 2014 The Korean Society of Radiology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Thoracic Imaging
Ryu, Yon Ju
Chun, Eun Mi
Lee, Soon Nam
Shim, Sung Shin
Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title_full Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title_fullStr Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title_full_unstemmed Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title_short Progressive Multiple Cystic Changes in Both Lungs in a Patient Treated with Gefitinib for Lung Adenocarcinoma with Multiple Lung Metastases
title_sort progressive multiple cystic changes in both lungs in a patient treated with gefitinib for lung adenocarcinoma with multiple lung metastases
topic Thoracic Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955799/
https://www.ncbi.nlm.nih.gov/pubmed/24642811
http://dx.doi.org/10.3348/kjr.2014.15.2.300
work_keys_str_mv AT ryuyonju progressivemultiplecysticchangesinbothlungsinapatienttreatedwithgefitinibforlungadenocarcinomawithmultiplelungmetastases
AT chuneunmi progressivemultiplecysticchangesinbothlungsinapatienttreatedwithgefitinibforlungadenocarcinomawithmultiplelungmetastases
AT leesoonnam progressivemultiplecysticchangesinbothlungsinapatienttreatedwithgefitinibforlungadenocarcinomawithmultiplelungmetastases
AT shimsungshin progressivemultiplecysticchangesinbothlungsinapatienttreatedwithgefitinibforlungadenocarcinomawithmultiplelungmetastases

Ejemplares similares